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Type VII collagen is the predominant, if not the exclusive, 
component of the anchoring fibrils. In this study, we have 
examined the expression of the type VII collagen gene in 
human skin fibroblasts and keratinocytes in culture by 
Northern analyses and immunocytochemistry. Type VII 
collagen gene expression was greatly enhanced in all cell 
strains studied after stimulation by transforming growth fac-
tor-fJ (TGF-fJ)· However, no definitive correlation between 
the donor age and the magnitude ofTGF-fJ response could be 
made. In contrast, the basal expression of the type VII colla-
gen gene was shown to decrease in an age-dependent manner 
in fibroblasts. The pro-inflammatory cytokines interleukin-
IjJ (IL-lfJ) and tumor necrosis factor-a (TNF-a) were shown 
C ollagens comprise a family of closely related yet ge-netically distinct proteins, and at present 18 collagens (types I-XVIII) have been characterized either at the protein and/or nucleic acid level [1 -4]. Among these 18 collagens, at least 11 of them have been identified 
in the skin [5]. Some of the collagens present in the skin, such as type 
VII collagen, demonstrate a topographically restricted localization. 
Specifically, type VII collagen is the predominant, if not the exclu-
sive, component of the anchoring fibrils, attachment structures 
present in the basement membrane zone of stratified squamous epi-
thelia, i.e., the skin, the mucous membranes, and the cornea of the 
eye [6,7]. 
Previous studies utilizing immunologic techniques have sug-
gested that both dermal fibroblasts and epidermal keratinocytes in 
culture synthesize type VII collagen [8 -10]. More recently, cloning 
of human type VII collagen cDNAs has allowed demonstration of 
the corresponding gene expression at the mRNA level [11,12]. 
Northern analyses and immunocytochemistry have demonstrated 
its upregulation by transforming growth factor-p (TGF-p) [13,14] . 
The presence of anchoring fibrils is apparently critical for the 
stability of the cutaneous basement membrane zone, because struc-
tural abnormalities, paucity, or even absence of anchoring fibrils 
manifest clinically as the dystrophic (scarring) forms of epidermoly-
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to elevate type VII collagen mRNA levels in a dose-depen-
dent manner. This response was inversely related to the 
donor age of the cell cultures. The attenuated response of 
cells from older individuals to TNF-a and IL-lfJ was specific 
for type VII collagen gene expression, because, in the same 
experiments, collagenase gene expression was strongly ele-
vated by the two cytokines. Our data suggest that type VII 
collagen gene expression is subject to modulation by the 
cytokine network, which may playa role in controlling an-
choring fibril assembly in normal skin and in pathologic 
conditions characterized by altered deposition of type VII 
collagen. Key words: collagen gene expression/donor age/cytokine 
responses. ] Ittvest Dermatoi102:205 -209, 1994 
sis bullosa (EB), characterized by cutaneous fragility and tendency 
to sub-basal lamina blister formation [15-17J. 
A previous study has suggested that topical application of a1l-
trans-retinoic acid onto photodamaged skin results in a significant 
increase in the number of anchoring fibrils, which were apparently 
scarce in the untreated skin [18]. Furthermore, recent studies have 
suggested that the effects of all-trans-retinoic acid upon skin could 
be mediated, at least in part, by increased expression of TGF-p 
[19,20J. In this study, we have examined the response of fibroblasts 
and keratinocytes from individuals of varying ages to TGF-p, as 
well as to tumor necrosis factor-a (TNF-a) and interleukin-1p (IL-
1P), members of the cytokine network, which have been previously 
shown to modulate the expression of the extracellular matrix 
genes [21 J. 
MATERIALS AND METHODS 
Cell Cultures Human neonatal epidermal keratinocytes from foreskin or 
adult keratinocytes from sun-protected mammoplasry skin specimens were 
obtained from Clonetics Corp. (San Diego, CAl, and the cultures were 
maintained in serum-free, low-calcium (0.15 mM) keratinocyte growth 
medium supplemented with epidermal growth factor, hydrocortisone, insu-
lin, and bovine pituitary extract (KGM; Clonetics). Human skin fibroblast 
cultures were established from mammoplasry skin specimens obtained from 
sun-protected areas from individuals of varying ages. Fibroblast cultures 
from fetal skin were obtained from the American Type Culture Collection 
(ATCC, Rockville, MD). The fibroblast cultures were maintained in Dul-
becco's modified Eagle's medium (DMEM) supplemented with 2 mM glu-
tamine, 50,ug/ml streptomycin, 200 U/ml penicillin-G, and 10% fetal 
bovine serum (PBS). One hour prior to the addition of growth factors, the 
fibroblast cultures were rinsed with DMEM and placed in DMEM contain-
ing 1% FBS. 
TGF-pt, purified from bovine bone, and human recombinant TGF-/12 
were kindly provided by Dr. David R. Olsen, Celtrix Laboratories, Santa 
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Clara, CA. Human recombinant IL-1P and TNF-(l! were purchased from 
Boehringer Mannheim, Indianapolis, IN. 
Indirect Immunofluorescence Cell cultures were established on 
chamber slides (Nunc Co., Naperville, IL), stained with a monoclonal anti-
type VII collagen antibody L3D J22] (kindly provided by Dr. R.~. Brigga-
man, University of North Caroitna, Chapel Hill), and processed \11 parallel, 
as described previously [10,13]. 
Northern Analysis Total RNA was isolated either by a single-step proce-
dure [23] or by CsCl2 density gradient centrifugation [24]. Northern filters 
were prepared as described elsewhere [11,13], and hybridized with a 1.9-kb 
human type VII collagen cDNA K-131 [11] . The same filters were rehybrid-
ized with a human GAPDH cDNA (Ame.rican Type Culture Collection, 
Rockville, MD), as described previously [13]. 
RESULTS 
TGF-fiUpregulates Tr~e VII Collagen. Synthesis in CUltur.ed 
Fibroblasts from IndIVIduals of Varymg Ages To exanune 
the effect of age on type VII collagen gene expression, fibroblast 
cultures were derived from four subjects varying from 8 weeks fetal 
gestation to 75 years of age. All cultures were examined at passages 
3 - 5 under identical culture conditions. A monoclonal antibody 
(L3D) recognizing an epitope within the NC-l domain was utilized 
for indirect immunofluorescence, and the intensity of the immuno-
signal was taken as a semi-quantitative indicator of the level of type 
VII collagen production (Fig 1). Immunostaining of control cul-
tures incubated in medium containing 1 % FBS demonstrated a low, 
yet clearly detectable, level of type VII collagen epitopes in cultures 
from all ages (Fig lA - D). Because ohhe low level ohhe signal, no 
precise assessment of the level of type VI.I collagen gene expressi~n 
in control fibroblast cultures as a functIOn of the age of the skm 
donor could be made. 
To examine the effect ofTGF-fil on type VII collagen synthesis, 
parallel cultures were incubated with TGF-fil (10 ngjml). This 
concentration was previously shown to result in maximal enhance-
ment of type VII collagen synthesis in cultured keratinocytes [13] . 
The addition ofTGF-fil to the culture medium markedly enhanced 
type VII collagen synthesis in all four donor cultures, as visualized 
by indirect immunofluorescence (Fig lE-H) after 48 h of incuba-
tion. In this experiment, the cell cultures established from a 75-
year-old individual appeared to be somewhat less responsive to 
TGF-fil, as judged by the intensity of the immunofluorescence 
staining (Fig IH) . The cells established from the skin of an 8-week-
old fetus also appeared to be less responsive to TGF-fi than the cells 
from the young adults (Fig lEversus IF). This finding may relate to 
the observation that type VII collagen gene expression is initiated 
relatively late during fetal skin development, and anchoring fibrils 
can not be detected ultrastructurally until about the twelfth week of 
gestation [25]. Thus, the cells from a fetus of8 weeks gestation may 
not have the capacity to fully respond to TGF-fi1. This interpreta-
tion was further supported by the observation that fibroblasts from a 
fetus of 20 weeks gestation were more responsive to TGF-fi at the 
mRNA level (see below). Nevertheless, fibroblasts derived from the 
skin of individuals of all ages examined in this experiment were 
clearly responsive to TGF-fil with respect to type VII collagen 
synthesis (Fig 1). Similar enhancement of type VII collagen synthe-
sis was also noted in the presence of TGF-pz (not shown). 
Effects ofTGF-fi on Type VII Collagen mRNA Levels The 
effects of donor age and response to TGF-fi were also examined at 
the mRNA level. As iJlustrated by Fig 2, Northern analyses with a 
human type VII collagen cDNA of total RNA isolated from three 
cell cultures established from individuals of 23,41, or 84 years of 
age demonstrated an age-dependent decrease in the basal level of 
type VII collagen gene expression. Specifically, the levels of type 
VII collagen mRNAs, after correction for the levels of glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) mRNA in the same 
RNA preparations, in cultures from a 23-year-old donor were ap-
proximately twice that noted in the 84-year-old donor's culture (Fig 
2). An intermediate level was noted in cultures established from the 
41-year-old individual. 
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Figure 1. Stimulation of type VII collagen synthesis by TGF-pl in fibro-
blast cultures established from individuals of varying ages. The cell cultures 
were established from fetal (8-week gestation; A and E ), 21-year-old (B and 
F), 55-year-old (C and G), or 75-year-old (D and H) individuals. The fibro-
blast cultures were incubated in parallel without (A-D) or with (E-H) 
TGF-,81 (10 ng/ml) for 48 h. The type VII collagen epitopes were visual-
ized by immunostaining with a monoclonal antibody, ~D, as described in 
Materials mId Methods. lmmunostaining is identified by arrows. Bar, 200 11m. 
To examine the response of the fibroblast cultures to TGF-fi at 
the mRNA level, the cultures shown in Fig 2 were also incubated in 
parallel with TGF-fil (10 ngjml). The results indicated that all 
three cell cultures responded to TGF-fJ, and the extent of stimula-
tion varied from 1.6 to 4.8 times (Table I). Similar enhancement of 
type VII collagen gene expression, as determined at the mRNA 
level, was observed in five additional cell strains, and the stimulation 
by TGF-fi varied from 2.2 to lOA times (Table I). Thus, these 
experiments, which examined a total of 12 fibroblast cell strains 
established from individuals varying from 8 weeks fetal gestation to 
84 years of age, collectively indicated that cultured skin fibroblasts 
from normal individuals are responsive to TGF-p with respect to 
type VII collagen gene expression. 
TGF-fi Enhances the Synthesis of Type VII Collagen in Epi-
dermal Keratinocytes To examine the possible age variation 
and the enhancement of type VII collagen synthesis by TGF-fi in 
cultured keratinocytes, indirect immunofluorescence analyses were 
performed on neonatal and adult keratinocytes incubated for 48 h 
with or without TGF-fil (10 ngjml) . Clearly detectable immuno-
signal was observed in both types of keratinocyte cultures (not 
shown) . Furthermore, a markedly enhanced immunosignal in 
TGF-fil-treated cultures was noted, and the enhancement ap-
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Figure 2. Effect of age of the donors of tissue specimens used to establish 
fibroblast cultures on type VII collagen gene expression. Fibroblast cultures 
were established from individuals of 23,41. or 84 years of age. total RNA 
w as isolated. and Northern hybridizations were performed with O'l(VII) 
collagen and GAPDH cDNAs (A). The relative levels of the 0'1 (VII) colla-
gen mRNAs as a function of age. as determined by scanning densitometry of 
the mRNAs. after correction for the levels of the GAPDH mRNA in the 
same preparation, are indicated in B. 
peared to be equally strong in neonatal and adult keratinocyte cul-
tures. The enhancement of type VII collagen gene expression by 
TGF-p in these cultures was also demonstrated at the mRNA level. 
in a similar manner to that shown previously [13]. 
Effects of IL-tp on Type vn Collagen Gene Expression in 
Dermal Fibroblasts To examine the effects of other growth 
factors. cultured fibroblasts were first incubated in the presence of 
IL-1P, in concentrations varying from 0 to lOU I mi. Incubation of 
cells from a 19-year - old individual demonstrated a marked. up to 
twelvefold, enhancement of type VII collagen gene expression in a 
Table I. TGF-p Stimulation of Type VII Collagen 
Gene Expression" 
Fibroblast 
Donor 
20-week-old fetus 
Newborn 1 
N ewborn 2 
Newborn 3 
23 year oldb 
41 year oldb 
73 year old 
84 year oldb 
Fold Stimulation 
of 0'1 (VII) mRNA by 
TGF-fi 
lOA 
2.5 
3.2 
4.9 
1.6 
2.0 
2.2 
4.8 
• Cultured fibrob lasts were incubated for 24 h with or withoutTGF-p (10 ng/ml). At 
the end of incubations, total RNA was extracted and analyzed by Northern hybridiza-
tion for rype VII collagen gene expression. Filters were re-hybridize~ with a GAPDH 
cDNA as a control. Autoradiograms were analyzed by scamung denSItometry. and the 
extent of stimulation of rype VII collagen mRNA by TGF-ft was calculated after 
correction for GAPDH mRNA levels in the same RNA preparations. 
• These donors are the same as in Fig 2. 
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Figure 3. Effects of IL-1fi on type VII collagen gene expression in dermal 
fibroblast cultures established from the skin of individuals of varying ages. 
A) Fibroblast cultures established either from a 19-year-old or a 73-year-old 
individual were incubated with IL-lfi in varying concentrations (0-10 UI 
mI) for 24 h. Total RNA was isolated and the 0'1 (VII) collagen and GAPDH 
mRNAs were detected by Northern hybridizations with the corresponding 
cDNAs. B) A set of fibroblast cultures established from the skin of individu-
als varying from 1 month to 74 years of age were incubated without or with 
IL-lfi (1 U/ml) for 24 h. and the enhancement of 0'1 (VII) collagen mRNA 
levels was determined by scanning densitometry of Northern blots. The 
relative values. after correction by GAPDH levels in the corresponding 
mRNA samples. are depicted. 
dose-dependent manner (Fig 3A). Similar, although less pro-
nounced. enhancement was noted in cultures established from a 
73-year-old individual (Fig 3A). Further analysis of fibroblast cul-
tures established from individuals varying from 1 month to 74 years 
of age demonstrated that the response to IL-1P diminished with 
advancing age of the donor (Fig 3B). Specifically, the enhancement 
of the al (VII) collagen mRNA levels in fibroblast cultures from the 
1-month-old donor incubated with IL-1P (1 U/mI) was approxi-
mately eightfold, whereas little enhancement was noted in the cul-
tures from a 74-year-old donor (Fig 3B). Thus. human dermal 
fibroblasts in cultures established from younger donors demonstrate 
a clear enhancement of type VII collagen gene expression by IL-lp. 
However. this response was inversely related to the donor age of the 
cell cultures. and the eldest individuals' cells showed lesser. and 
somewhat variable, response. This variability may reflect the low 
level of expression in the elderly individuals. 
Effects ofTNF-C\' on Type VII Collagen Gene Expression in 
Dermal Fibroblasts To further extend the investigation of ef-
fects of the cytokine network on type VII collagen gene expression. 
fibroblast cultures established from 21- and 73-year-old donors 
were incubated with varying concentrations of TNF-a, a potent 
inhibitor of type I collagen gene expression [26-29]. Incubation of 
fibroblast cultures established from the 21-year-old donor with 
TNF-C\' resul ted in clear enhancement of the type VII collagen gene 
expression, - 2.5-times enhancement being noted in the presence of 
20 ng/ ml ofTNF-C\' (Fig 4) . In contrast, the cell cultures established 
I 
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Figure 4. Effects of TNF-a on type VII collagen gene expression in fibro-
blast cultures established from skin of donors of 21 or 73 years of age. The 
fibroblast cultures were incubated with TNF-a in concentrations varying 
from 0 to 20 ng/m!. Northern hybridizations depict the presence of al (VII) 
collagen and GAPDH mRNAs. 
from the 73-year-old individual demonstrated essentially no 
change in the presence ofTNF-a in concentrations up to 20 ng/mI, 
after correction for the densitometric values of the GAPDH mRNA 
levels in the same samples (Fig 4). It should be noted that the latter 
cells were clearly responsive to TNF-a with respect to collagenase 
gene expression, which was increased by up to 6.2 times in the 
presence of TNF-a (not shown). Thus, the cultured human skin 
fibroblasts appear to demonstrate a differential, age-dependent re-
sponse to TNF-a. 
DJSCUSSION 
The critical importance of anchoring fibrils in providing the integ-
rity to the cutaneous basement membrane zone is attested to by the 
fact that abnormalities in the synthesis of type VII collagen or its 
assembly to anchoring fibrils result in a scarring blistering disease, 
the dystrophic form of EB [15 - 17]. In fact, we have recently dem-
onstrated that some of the recessive dystrophic EB patients contain 
structural mutations in the al(VII) collagen gene [30,31], whereas 
other studies have suggested deficient expression on the transla-
tional or post-translational level [32] . These observations have then 
suggested that uyregulation of type VII collagen gene expression 
might be helpfu in ameliorating or even reversing the blistering 
tendency in some cases with the dystrophic forms of EB [15]. 
Previous studies have indicated that TGF-pl and TGF-P2, mem-
bers of the pleiotropic TGF-p cytokine family, are capable of upreg-
ulating type VII collagen gene expression in cultured dermal fibro-
blasts and epidermal keratinocytes [13,14]. In this study, we have 
extended these observations to a variety of fibroblast cultures estab-
lished from individuals varying from 8 weeks fetal gestation to 84 
years of age . The studies on fibroblasts demonstrate that cultures 
established from any of the donors of any age studied respond sig-
nificantly to TGF-p by upregulating their type VII collagen gene 
expression, as detected either by indirect immunofluorescence at 
the protein level or by Northern hybridizations at the mRNA level. 
However, no apparent difference in the degree of response to TGF-
P could be noted between cultures established from individuals of 
varying ages. Recent indications in the literature have suggested 
that the number of anchoring fibrils may decrease with advancing 
age on the sun-exposed area of skin [18]. Thus, some age-associated 
manifestations in the skin, such as fragility and impaired epidermal 
wound healing, might be attributable to reduced anchoring fibrils 
and diminished type VII collagen synthesis in the elderly individ-
uals. 
In contrast to TGF-j3, no information has been available on the 
effects of other cytokines on type VII collagen gene expression. In 
this study, two members of the cytokine network, IL-1fi and TNF-
a, were tested for their effects on type VII collagen gene expression 
in human skin fibroblast cultures. These two cytokines in general 
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playa role in tissue remodeling and degradation by modulating the 
biosynthesis of the extracellular matrix macromolecules and by en-
hancing the synthesis of proteolytic enzymes [21,33]. In this study, 
IL-tp was shown to markedly elevate type VII collagen mRNA 
levels in fibroblast cultures established from young individuals, and 
the response diminished with advancing age of the donor individu_ 
als. The reasons for the age-dependent decrease in the responsive-
ness to IL-1P are not clear, but they could relate to the number of 
functional IL-1 receptors, or conversely, could reflect induction of 
receptor antagonists in the cultures. 
As indicated above, TNF-a has been shown previously to de-
crease type I collagen gene expression and to antagonize the TGF-p 
upregulation of type I collagen gene expression [26-29]' In con-
trast, TNF-a markedly enhanced type VII collagen gene expres-
sion, as detected by the presence of elevated a1(VII) collagen 
mRNAs. However, this response was noted only in younger donors. 
Thus, both IL-1P and TNF-a demonstrate a similar pattern of up-
regulatio~ ~f type VII ~oll~gen gene expression. These data may 
suggest SImIlar trans-aCtIVatIOn pathways and/or shared responsive 
cis-elements in the a1(VII) collagen promoter region. 
In conclusion, type VII collagen gene expression is clearly subject 
to modulation by the cytokine network, and the interactions of 
various growth factors and cytokines may playa role in physiologic 
conditions, such as anchoring fibril assembly during fetal develop_ 
ment, or in repair processes, such as formation of a stable dermal_ 
epidermal junction during epidermal wound healing. Furthermore, 
these observations suggest pharmacologic potential for cytokines 
either alone or in combination to correct states characterized by 
deficient deposition of type VII collagen and the anchoring fibrils in 
diseases, such as certain forms of dystrophic epidermolysis bullosa. 
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